These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10661388)

  • 21. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
    Morley PS; Townsend HG; Bogdan JR; Haines DM
    J Am Vet Med Assoc; 1999 Jul; 215(1):61-6. PubMed ID: 10397067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine.
    Newton JR; Lakhani KH; Wood JL; Baker DJ
    Prev Vet Med; 2000 Jul; 46(2):129-41. PubMed ID: 10878300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the response to an accelerated immunisation schedule using a canarypox-vectored equine influenza vaccine, shortened interdose intervals and vaccination of young foals.
    Minke JM; El-Hage CM; Tazawa P; Homer D; Lemaitre L; Cozette V; Gilkerson JR; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():137-9. PubMed ID: 21711312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
    Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
    Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological investigation of racehorse vaccination against equine influenza in Morocco.
    Dilai M; Piro M; Fougerolle S; El Harrak M; Mahir W; El Mourid R; Legrand L; Paillot R; Fassi Fihri O
    Vet Microbiol; 2018 Sep; 223():153-159. PubMed ID: 30173741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses.
    Ryan M; Gildea S; Walsh C; Cullinane A
    Equine Vet J; 2015 Nov; 47(6):662-6. PubMed ID: 25238593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
    Gildea S; Quinlivan M; Murphy BA; Cullinane A
    Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak.
    Bryant NA; Paillot R; Rash AS; Medcalf E; Montesso F; Ross J; Watson J; Jeggo M; Lewis NS; Newton JR; Elton DM
    Vet Res; 2010; 41(2):19. PubMed ID: 19863903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses.
    Morley PS; Hanson LK; Bogdan JR; Townsend HG; Appleton JA; Haines DM
    Vet Microbiol; 1995 Jun; 45(1):81-92. PubMed ID: 7653031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses.
    Bogdan JR; Morley PS; Townsend HG; Haines DM
    Can J Vet Res; 1993 Apr; 57(2):126-30. PubMed ID: 8387870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective serological survey for influenza in horses from Brazil.
    Daly JM; Megid J; Langoni H; de Nardi Júnior G; Ribeiro MG
    Braz J Microbiol; 2021 Mar; 52(1):461-466. PubMed ID: 33175343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of equine influenza virus shedding and infectivity in immunised horses after experimental infection with EIV A/eq2/Richmond/1/07.
    Paillot R; Prowse L; Montesso F; Stewart B; Jordon L; Newton JR; Gilkerson JR
    Vet Microbiol; 2013 Sep; 166(1-2):22-34. PubMed ID: 23769636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for influenza infection in vaccinated racehorses: lessons from an outbreak in Newmarket, UK in 2003.
    Barquero N; Daly JM; Newton JR
    Vaccine; 2007 Oct; 25(43):7520-9. PubMed ID: 17889409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
    Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.
    Cullinane A; Weld J; Osborne M; Nelly M; Mcbride C; Walsh C
    Vet J; 2001 Mar; 161(2):174-85. PubMed ID: 11243687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.